Moderna Inc (Moderna Inc (MRNA) has risen Friday morning, with the stock rising 5.33% in pre-market trading to 156.29.
MRNA's short-term technical score of 70 indicates that the stock has traded more bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 114 out of 146 industries, MRNA ranks higher than 79% of stocks.
Moderna Inc has fallen 2.34% over the past month, closing at $173.16 on January 29. During this period of time, the stock fell as low as $144.79 and as high as $189.26. MRNA has an average analyst recommendation of Buy. The company has an average price target of $138.08.
Moderna Inc has a Long-Term Technical rank of 68. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 32% of the market scoring higher. In the Biotechnology industry which is number 105 by this metric, MRNA ranks better than 69% of stocks.
Important Dates for Investors in MRNA:
-Moderna Inc is set to release earnings on 5/26/2021. During their last earnings release the company posted EPS of $-1.61. -We do not have a set dividend date for Moderna Inc at this time. Click Here to get the full Stock Score Report on Moderna Inc (MRNA) Stock.
